Kestra Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Kestra Advisory Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.33M	Buy	26,063 +6,073	+30%	+$758K	0.01%	1011
2025 Q4	$2.44M	Buy	19,990 +474	+2%	+$54.3K	0.01%	1108
2025 Q3	$1.96M	Sell	19,516 -2,717	-12%	-$245K	0.01%	1163
2025 Q2	$1.84M	Sell	22,233 -69	-0.3%	-$5.5K	0.01%	1126
2025 Q1	$1.81M	Sell	22,302 -3,539	-14%	-$316K	0.01%	1033
2024 Q4	$2.33M	Sell	25,841 -8,209	-24%	-$795K	0.01%	921
2024 Q3	$3.36M	Sell	34,050 -4,238	-11%	-$416K	0.02%	724
2024 Q2	$3.55M	Buy	38,288 +8,819	+30%	+$791K	0.02%	711
2024 Q1	$2.8M	Buy	29,469 +9,114	+45%	+$846K	0.02%	736
2023 Q4	$1.82M	Sell	20,355 -3,003	-13%	-$223K	0.01%	835
2023 Q3	$1.71M	Buy	23,358 +1,265	+6%	+$101K	0.02%	747
2023 Q2	$1.84M	Buy	22,093 +202	+0.9%	+$16.9K	0.02%	704
2023 Q1	$1.67M	Sell	21,891 -693	-3%	-$57.5K	0.02%	720
2022 Q4	$1.87M	Sell	22,584 -581	-3%	-$47K	0.02%	776
2022 Q3	$1.84M	Sell	23,165 -7,768	-25%	-$655K	0.02%	701
2022 Q2	$2.3M	Sell	30,933 -706	-2%	-$53K	0.02%	624
2022 Q1	$2.84M	Buy	31,639 +1,499	+5%	+$138K	0.03%	552
2021 Q4	$3.37M	Sell	30,140 -3,136	-9%	-$378K	0.03%	498
2021 Q3	$4.18M	Sell	33,276 -6,024	-15%	-$776K	0.04%	451
2021 Q2	$5.32M	Sell	39,300 -1,934	-5%	-$254K	0.06%	344
2021 Q1	$5.59M	Buy	41,234 +13,801	+50%	+$2.07M	0.07%	311
2020 Q4	$3.95M	Buy	27,433 +7,704	+39%	+$987K	0.05%	394
2020 Q3	$2.2M	Buy	+19,729	New	+$2.21M	0.04%	408

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Kestra Advisory Services's XBI Position: Q1 2026 in Review

Kestra Advisory Services increased its State Street SPDR S&P Biotech ETF (XBI) stake by 30% in Q1 2026, buying an estimated $758K and bringing the position to 26,063 shares worth $3.33M. The position accounts for 0.01% of the portfolio, ranked #1011.

Kestra Advisory Services first reported a position in XBI in Q3 2020 and has held it in 23 quarters since. The position peaked at $5.59M in Q1 2021. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Kestra Advisory Services held 26,063 shares of State Street SPDR S&P Biotech ETF worth $3.33M as of Q1 2026.
Kestra Advisory Services bought 6,073 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $758K.
State Street SPDR S&P Biotech ETF made up 0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #1011 holding.
Kestra Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 23 quarters since.
Kestra Advisory Services's State Street SPDR S&P Biotech ETF position peaked at $5.59M in Q1 2021.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.